A research team led by Prof. Chu Yannan at the Hefei Institutes of Physical Science, Chinese Academy of Sciences, has ...

SYRACUSE, N.Y. — Crouse Health has a new tool to help you detect and treat lung cancer earlier and in a less invasive way. The Ion Robotic System from Intuitive allows for a minimally invasive biopsy ...

A new meta-analysis provided high-quality evidence demonstrating that video-assisted thoracoscopic surgery (VATS) significantly reduces the risk for death by 21% compared with open lobectomy in ...

Robotic-assisted bronchoscopy detected early-stage lung cancer three times more frequently than traditional CT-guided biopsy, potentially improving patient survival outcomes. The robotic approach ...

Older individuals between the ages of 75 and 80 who are eligible for lung surgery may achieve survival outcomes comparable to younger patients following lung cancer screening, according to research ...

As the rates of late-stage lung cancer in nonsmokers rise in Canada, researchers are advocating for increased awareness and screening. According to the Canadian Cancer Society, lung cancer was ...

A state-of-the-art laboratory rolled into Cambria County Tuesday. The Thoracic Oncology Mobile Experience is an 18-wheel truck that travels across the country highlighting the latest robotic-assisted ...

has been cited by the following article: TITLE: Optimizing Lung Cancer Detection in CT Imaging: A Wavelet Multi-Layer Perceptron (WMLP) Approach Enhanced by Dragonfly Algorithm (DA) ...

HORRY COUNTY, SC (WMBF) - Conway Medical Center is using new robotic-assisted technology aimed at detecting lung cancer earlier and with greater accuracy. Pulmonologist Dr. Hafez Hayek said lung ...

TYLER, Texas (KLTV) - According to the American Cancer Society, Lung Cancer remains the deadliest cancer. With advanced technology, doctors can safely and accurately biopsy much smaller nodules in the ...

Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...

The FDA on Friday granted accelerated approval to zongertinib (Hernexeos) for non-squamous non-small cell lung cancer (NSCLC) patients harboring HER2 tyrosine kinase domain (TKD) activating mutations.